AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24982464 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC (vincristine, dactinomycin, and cyclophosphamide) with 1.5 g/m² of cyclophosphamide
Number of subjects: 856
Study 24982464 — intervention group
Group type: COMPARATOR
Intervention: VAI (vincristine, dactinomycin, and ifosfamide) with 6 g/m² of ifosfamide
Number of subjects: 856
Study 24982464 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC
Number of subjects: 856
Study 24982464 — intervention group
Group type: COMPARATOR
Intervention: VAI
Number of subjects: 856
Study 21945511 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0633 100 mg
Number of subjects: 0
Study 21945511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21945511 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0633 (various doses)
Number of subjects: 0
Study 21945511 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0633
Number of subjects: 0
Study 19244263 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine infusion for femoral nerve
Number of subjects: 24
Study 19244263 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine infusion for sciatic nerve
Number of subjects: 24
Study 19244263 — intervention group
Group type: COMPARATOR
Intervention: Comparison of EC50 for femoral vs sciatic nerve
Number of subjects: 24
Study 17120172 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with IV sedation
Number of subjects: 40
Study 17120172 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 40
Study 15102865 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated blood pressure measurement
Number of subjects: 20
Study 15102865 — intervention group
Group type: COMPARATOR
Intervention: Manual blood pressure measurement
Number of subjects: 20
Study 15102865 — intervention group
Group type: EXPERIMENTAL
Intervention: Triplicate blood pressure measurements
Number of subjects: 20
Study 15102865 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion
Number of subjects: 20
Study 15102865 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline infusion
Number of subjects: 20
Study 11984298 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (1200 IU.d‐1 for 30 days)
Number of subjects: 16
Study 11984298 — intervention group
Group type: COMPARATOR
Intervention: Placebo (safflower oil)
Number of subjects: 16
Study 11984298 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Vitamin E and Placebo)
Number of subjects: 16
Study 9788829 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography-guided ethanol septal reduction (2 to 5 mL of absolute ethanol injected into the septal artery)
Number of subjects: 33
Study 9788829 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography-guided ethanol septal reduction
Number of subjects: 33
Study 8610215 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular gold
Number of subjects: 128
Study 8610215 — intervention group
Group type: COMPARATOR
Intervention: Sulphasalazine
Number of subjects: 128
Study 2491521 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of oral calcium for 8 weeks
Number of subjects: 51
Study 2491521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 892953 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandrax + alcohol
Number of subjects: 0
Study 892953 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam + alcohol
Number of subjects: 0
Study 892953 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandrax + alcohol placebo
Number of subjects: 0
Study 892953 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug placebo + alcohol
Number of subjects: 0
Study 892953 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug + alcohol
Number of subjects: 0
Study 892953 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug + alcohol placebo
Number of subjects: 0
Study 31424421 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS plus MT
Number of subjects: 18
Study 31424421 — intervention group
Group type: COMPARATOR
Intervention: iTBS plus sham MT
Number of subjects: 18
Study 31424421 — intervention group
Group type: COMPARATOR
Intervention: sham iTBS plus MT
Number of subjects: 18
Study 28867442 — intervention group
Group type: EXPERIMENTAL
Intervention: Information about abortion safety
Number of subjects: 1200
Study 28867442 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no information)
Number of subjects: 1200
Study 24849943 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine epidural analgesia (EA)
Number of subjects: 488
Study 24849943 — intervention group
Group type: COMPARATOR
Intervention: Analgesia on request
Number of subjects: 488
Study 24021094 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Goal Attainment Program (PGAP) - 10 weekly individual sessions of structured active rehabilitation in addition to usual care.
Number of subjects: 100
Study 24021094 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care only (Control).
Number of subjects: 100
Study 24021094 — intervention group
Group type: EXPERIMENTAL
Intervention: PGAP intervention.
Number of subjects: 100
Study 22409094 — intervention group
Group type: EXPERIMENTAL
Intervention: PNI-based lifestyle intervention (progressive muscle relaxation, spiritual guided imagery, humor)
Number of subjects: 41
Study 22409094 — intervention group
Group type: EXPERIMENTAL
Intervention: PNI-based lifestyle intervention
Number of subjects: 41
Study 22409094 — intervention group
Group type: COMPARATOR
Intervention: Control group (receiving cognitive behavioral therapy and pharmacotherapy)
Number of subjects: 41
Study 19603054 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate (5‐MTHF) 15 mg/day for 3 weeks
Number of subjects: 15
Study 19603054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 17338790 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture for 10 weeks and probiotic treatment (living non‐pathogenic Enterococcus faecalis) for 7 weeks
Number of subjects: 17
Study 17338790 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with a laser pen that did not emit laser light and placebo drops
Number of subjects: 17
Study 17338790 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture and probiotics
Number of subjects: 17
Study 17338790 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study 15132303 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise training (3 sessions/week for 10 weeks)
Number of subjects: 102
Study 15132303 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 102
Study 11234548 — intervention group
Group type: EXPERIMENTAL
Intervention: German factor model of the Conners Parent Rating Scale (CPRS)
Number of subjects: 1394
Study 11234548 — intervention group
Group type: COMPARATOR
Intervention: U.S. factor model of the Conners Parent Rating Scale (CPRS)
Number of subjects: 1394
Study 9740919 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive management approach including preoperative evaluation, meticulous exenterative surgery, supervised immunotherapy, medical management with corticosteroids, patient self-cleansing, and close clinical follow-up.
Number of subjects: 0
Study 8031347 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine surfactant (4 g in 50 ml) delivered via bronchoscope
Number of subjects: 6
Study 10318325 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 29746813 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate injectable (DMPA)
Number of subjects: 68
Study 29746813 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 68
Study 29746813 — intervention group
Group type: COMPARATOR
Intervention: TearFlo Strips (TFS)
Number of subjects: 68
Study 29746813 — intervention group
Group type: COMPARATOR
Intervention: Cervicovaginal lavage (CVL)
Number of subjects: 68
Study 27127315 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin SR 10 mg
Number of subjects: 90
Study 27127315 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg
Number of subjects: 90
Study 27127315 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg
Number of subjects: 90
Study 25589782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target systolic BP <140 mm Hg)
Number of subjects: 2708
Study 25589782 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (<180 mm Hg)
Number of subjects: 2708
Study 23203138 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride XR 60 mg once daily for 10 days in healthy volunteers
Number of subjects: 349
Study 23203138 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride 60 mg XR once daily for either 2 weeks or 12 weeks in patients with overactive bladder
Number of subjects: 349
Study 23203138 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride XR 60 mg
Number of subjects: 349
Study 19828479 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 22
Study 19828479 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 22
Study 17710365 — intervention group
Group type: EXPERIMENTAL
Intervention: GLU (1.8 g x kg BW(‐1))
Number of subjects: 20
Study 17710365 — intervention group
Group type: EXPERIMENTAL
Intervention: GLU + FG (1.8 g x kg BW(‐1) + 1.99 +/‐ 0.20 mg x kg(‐1) 4‐hydroxyisoleucine)
Number of subjects: 20
Study 17710365 — intervention group
Group type: COMPARATOR
Intervention: GLU
Number of subjects: 20
Study 17710365 — intervention group
Group type: EXPERIMENTAL
Intervention: GLU + FG
Number of subjects: 20
Study 16150265 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge (24 hours postpartum)
Number of subjects: 430
Study 16150265 — intervention group
Group type: COMPARATOR
Intervention: Control (traditional discharge, more than 48 hours)
Number of subjects: 430
Study 12502663 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 1221
Study 10539835 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 2023
Study 10539835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2023
Study 7552517 — intervention group
Group type: EXPERIMENTAL
Intervention: Three 100 microgram doses of the inactivated HIV‐1 antigen in incomplete Freund's adjuvant (IFA)
Number of subjects: 0
Study 7552517 — intervention group
Group type: COMPARATOR
Intervention: Three doses of IFA alone
Number of subjects: 0
Study 1745512 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (2% liquid ophthalmic drop preparation, four drops three times per day for 6 weeks)
Number of subjects: 18
Study 1745512 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identically appearing solution, same dosing schedule and duration)
Number of subjects: 18
Study 6751182 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (nafcillin for 6 weeks plus gentamicin for 2 weeks) in parenteral drug addicts
Number of subjects: 78
Study 6751182 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (nafcillin for 6 weeks plus gentamicin for 2 weeks) in nonaddicts
Number of subjects: 78
Study 6751182 — intervention group
Group type: COMPARATOR
Intervention: Single therapy (nafcillin for 6 weeks) in both groups
Number of subjects: 78
Study 30779531 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab plus Axitinib
Number of subjects: 886
Study 30779531 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 886
Study 28579056 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based oculomotor training
Number of subjects: 11
Study 27488246 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 361
Study 27488246 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 361
Study 27488246 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 361
Study 25220861 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (10-40 mg/day)
Number of subjects: 232
Study 25220861 — intervention group
Group type: COMPARATOR
Intervention: Desipramine (50-200 mg/day)
Number of subjects: 232
Study 23545428 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible dose morphine/oxycodone (3 mg/2 mg to 24 mg/16 mg)
Number of subjects: 44
Study 23545428 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone/acetaminophen (5 mg/325 mg)
Number of subjects: 44
Study 23545428 — intervention group
Group type: COMPARATOR
Intervention: Fixed low-dose morphine/oxycodone (3 mg/2 mg)
Number of subjects: 44
Study 23545428 — intervention group
Group type: COMPARATOR
Intervention: Equianalgesic morphine/oxycodone
Number of subjects: 44
Study 23545428 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible dose morphine/oxycodone
Number of subjects: 44
Study 20593354 — intervention group
Group type: EXPERIMENTAL
Intervention: Water load of 25 ml/kg(BW) in 24 hours
Number of subjects: 20
Study 20593354 — intervention group
Group type: EXPERIMENTAL
Intervention: Water load of 25 ml/kg(BW) in 30 minutes
Number of subjects: 20
Study 18372584 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance type exercise training of moderate intensity most days of the week
Number of subjects: 0
Study 16650156 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment
Number of subjects: 7
Study 12824978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ritodrine (111 microg/min for 20 minutes)
Number of subjects: 74
Study 12824978 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin (0.4 mg)
Number of subjects: 74
Study 12824978 — intervention group
Group type: COMPARATOR
Intervention: Intravenous sodium chloride 0.9% (placebo)
Number of subjects: 74
Study 10638892 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 4 mg plus fentanyl 20 microg (Group A)
Number of subjects: 20
Study 10638892 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 10 mg (Group B)
Number of subjects: 20
Study 8683193 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion and exclusion tests with varying proportions of old targets to old nontargets and attention conditions (full or divided attention)
Number of subjects: 0
Study 8683193 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of similarity of old targets and old nontargets
Number of subjects: 0
Study 8683193 — intervention group
Group type: EXPERIMENTAL
Intervention: Source confusions in inclusion and exclusion tests
Number of subjects: 0
Study 8293735 — intervention group
Group type: EXPERIMENTAL
Intervention: Desirable cholesterol test results
Number of subjects: 0
Study 8293735 — intervention group
Group type: EXPERIMENTAL
Intervention: Borderline-high cholesterol test results
Number of subjects: 0
Study 8293735 — intervention group
Group type: EXPERIMENTAL
Intervention: Never tested group in community screening
Number of subjects: 0
Study 3090492 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel‐releasing Norplant implants
Number of subjects: 389
Study 3090492 — intervention group
Group type: COMPARATOR
Intervention: Copper intrauterine device
Number of subjects: 389
Study 30373734 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support for 1 year
Number of subjects: 355
Study 30373734 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 355
Study 26803397 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (12-week course)
Number of subjects: 4041
Study 26803397 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (treatment group in COMED, n=151)
Number of subjects: 4041
Study 26803397 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram-buproprion (combined treatment group in COMED, n=134)
Number of subjects: 4041
Study 26803397 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine-mirtazapine (combined treatment group in COMED, n=140)
Number of subjects: 4041
Study 26011971 — intervention group
Group type: EXPERIMENTAL
Intervention: LASEK
Number of subjects: 30
Study 26011971 — intervention group
Group type: COMPARATOR
Intervention: T-PRK
Number of subjects: 30
Study 24985393 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (10-week duration)
Number of subjects: 22
Study 24985393 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 22
Study 22917446 — intervention group
Group type: EXPERIMENTAL
Intervention: Legacy for ChildrenTM group-based parenting intervention model
Number of subjects: 0
Study 22917446 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study 21056807 — intervention group
Group type: EXPERIMENTAL
Intervention: IV diclofenac 37.5 mg
Number of subjects: 30
Study 21056807 — intervention group
Group type: COMPARATOR
Intervention: ketorolac 30 mg
Number of subjects: 30
Study 21056807 — intervention group
Group type: COMPARATOR
Intervention: oral acetylsalicylic acid (ASA) 325 mg
Number of subjects: 30
Study 21056807 — intervention group
Group type: COMPARATOR
Intervention: oral diclofenac 50 mg
Number of subjects: 30
Study 17693428 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment (appliance removal)
Number of subjects: 25
Study 17693428 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated group)
Number of subjects: 25
Study 15653006 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal estriol 0.5 mg/day
Number of subjects: 27
Study 15653006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 12410188 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily home PCA monitoring
Number of subjects: 4
Study 12410188 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 4
Study 10461058 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery (BCS)
Number of subjects: 340
Study 10461058 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy (control group)
Number of subjects: 340
Study 8891498 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 6
Study 8891498 — intervention group
Group type: COMPARATOR
Intervention: Running
Number of subjects: 6
Study 6826111 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyloestradiol plus 150 micrograms norgestrel
Number of subjects: 0
Study 6826111 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms ethinyloestradiol plus 250 micrograms norgestrel
Number of subjects: 0
Study 6826111 — intervention group
Group type: COMPARATOR
Intervention: 30 micrograms ethinyloestradiol alone
Number of subjects: 0
Study 6826111 — intervention group
Group type: COMPARATOR
Intervention: 30 micrograms ethinyloestradiol plus 2.5 mg norethisterone
Number of subjects: 0
Study 31150063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold exposure in lean men
Number of subjects: 21
Study 31150063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold exposure in men with obesity
Number of subjects: 21
Study 31150063 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower critical temperature (Tlc) in lean men
Number of subjects: 21
Study 31150063 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower critical temperature (Tlc) in men with obesity
Number of subjects: 21
Study 30572923 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative stereotactic radiosurgery (SRS) followed by surgical resection
Number of subjects: 0
Study 27751217 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose gamma globulin pulse therapy
Number of subjects: 33
Study 27751217 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 33
Study 25404441 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Assisted Learning (PAL)
Number of subjects: 70
Study 25404441 — intervention group
Group type: COMPARATOR
Intervention: Expert Assisted Learning (EAL)
Number of subjects: 70
Study 23224336 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes management program
Number of subjects: 52
Study 23224336 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 52
Study 19890680 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted THA
Number of subjects: 130
Study 19890680 — intervention group
Group type: COMPARATOR
Intervention: Hand-rasping THA
Number of subjects: 130
Study 17555114 — intervention group
Group type: EXPERIMENTAL
Intervention: Human recombinant erythropoietic agents (specific dosage schemes not provided)
Number of subjects: 0
Study 17555114 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbopoietin alpha (specific dosage schemes not provided)
Number of subjects: 0
Study 17555114 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous erythropoietin level (as a response-prediction factor)
Number of subjects: 0
Study 16343114 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin 600 mg administered orally 1 hour before surgery
Number of subjects: 256
Study 16343114 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered orally 1 hour before surgery
Number of subjects: 256
Study 11966551 — intervention group
Group type: EXPERIMENTAL
Intervention: NO-generating system combined with lidocaine (5%)
Number of subjects: 100
Study 11966551 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (NO-generating gel)
Number of subjects: 100
Study 9879477 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 50
Study 7695460 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention Team group
Number of subjects: 803
Study 7695460 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education group
Number of subjects: 803
Study 7695460 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 803
Study 1523211 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorionic Villus Sampling (CVS)
Number of subjects: 2009
Study 1523211 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniocentesis
Number of subjects: 2009
Study 6342359 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive radiation therapy (RT) followed by chemotherapy (CT)
Number of subjects: 164
Study 6342359 — intervention group
Group type: COMPARATOR
Intervention: Involved field RT, IF RT followed by CT, total nodal RT, or total lymphoid irradiation
Number of subjects: 164
Study 31797710 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnitine infusion over 10 min 2 hours prior to radiocontrast administration and 24 hours post CT
Number of subjects: 0